BACTERIAL AND SENSITIVITY PATTERN OF PATHOGENS CAUSING VENTILATOR-ASSOCIATED PNEUMONIA IN INTENSIVE CARE UNIT
نویسندگان
چکیده
Highlight:1. Antimicrobial resistance bacteria isolated from VAP patients are often associated with high mortality and length of hospital stay. 2. Mortality in was 33.3% the group had a longer stay compared to non-VAP group. 3. The three most predominant that were found A. baumannii, P. aeruginosa, K. pneumoniae. Cefoperazone-sulbactam, meropenem amikacin more than 70% sensitive against these bacteria.Abstract:Background: Ventilator-Associated Pneumonia (VAP) is common nosocomial infection Intensive Care Unit (ICU). resistant Objective: This study aimed analyze pattern sensitivity among pathogens caused ICU. Materials Methods: conducted retrospectively by extracting data bacterial isolates sputum specimens Laboratory Clinical Microbiology, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia confirming clinical on suffering ICU ward. started January until December 2017. Results: total 148 isolated, 18 them diagnosed as VAP, 130 not VAP. Acinetobacter baumannii many 38 (9%) followed Pseudomonas aeruginosa 22 (2%), E. coli 16 (7%), Klebsiella pneumoniae 11 (1%). showed rate above cefoperazone-sulbactam (SCF), (MEM) (AK). Conclusion: cefoperazone-sulbactam, meropenem, amikacin.
منابع مشابه
Does Re-intubation Increased Risk of Ventilator- Associated Pneumonia (VAP) in Pediatric Intensive Care Unit Patients?
Introduction:ventilator- associated pneumonia(VAP),as defined by the centers for disease control and prevention (CDC),is a pneumonia that occurs in a patient receiving mechanical ventilation that develops 48 hours or more after initiation of ventilation.re-intubation which occur within 72 hours of planned extubation may effect VAP incidence.the aim of this study was to determine VAP incidence i...
متن کاملMethicillin Resistant Staphylococcus Aureus in Ventilator Associated Pneumonia in Toxicological Intensive Care Unit
Background: Methicillin resistant Staphylococus Aureus (MRSA) is a cause of nosocomial infections at intensive care unit (ICU), which imposes a high mortality and morbidity on the health care systems. The objective of this study was to evaluate the role of MRSA in patients with clinically suspected ventilator associated pneumonia (VAP) in toxicological ICU admitted patients.Methods: This ...
متن کاملEvaluation of Microorganisms Causing Ventilator-Associated Pneumonia in a Pediatric Intensive Care Unit.
OBJECTIVE The aim of this study was to identify microorganisms causing ventilator-associated pneumonia (VAP) and also study the antibiotic resistance/susceptibility. MATERIALS AND METHODS We retrospectively assessed microorganisms isolated from patients diagnosed with VAP in a pediatric intensive care unit between January 1, 2014, and June 30, 2016. RESULTS We included 44 patients diagnosed...
متن کاملThe prevalence of Mycoplasma pneumoniae infection in patients with ventilator-associated pneumonia hospitalized in intensive care unit
Background: Ventilator-associated pneumonia (VAP) is a type of hospital acquired pneumonia with the mortality rate between 27% and 76% that develops more than 48–72 h after endotracheal intubation. Possible causes leading to this infection can be Mycoplasma pneumoniae. The objective of this study was to determine the presence of Mycoplasma pneumoniae in bronchoalveolar samples of patients with ...
متن کاملTreatment Protocol of Ventilator-Associated Pneumonia based on Microbial Susceptibility in Pediatric Intensive Care Unit, Isfahan, Iran
Background Choosing a unique empiric treatment for ventilator associated pneumonia (VAP) can be challenging. We aimed to determine the antimicrobial susceptibility pattern of Intensive Care Unit (ICU) of the only referral pediatric hospital in Isfahan in order to design the optimal empiric treatment protocol. Materials and Methods: </strong...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Majalah Biomorfologi
سال: 2022
ISSN: ['0215-8833', '2716-0920']
DOI: https://doi.org/10.20473/mbiom.v32i1.2022.22-28